GLP-1 Receptor Agonists

Semaglutide and Tirzepatide Semaglutide Tirzepatide Saxenda Mechanism of Action

Oral Semaglutide 25 mg Shows Larger Metabolic Gains With At Least 15% Weight Loss in OASIS-4

An exploratory analysis presented at ObesityWeek 2025 links greater weight reduction to bigger improvements in glycemia plus cardiovascular risk markers.